Bovilis Bovivac S

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: VMD (Veterinary Medicines Directorate)

العنصر النشط:

Salmonella dublin, Salmonella typhimurium

متاح من:

MSD Animal Health UK Limited

ATC رمز:

QI02AB05

INN (الاسم الدولي):

Salmonella dublin, Salmonella typhimurium

الشكل الصيدلاني:

Suspension for injection

نوع الوصفة الطبية :

POM-V - Prescription Only Medicine – Veterinarian

المجموعة العلاجية:

Cattle

المجال العلاجي:

Inactivated Bacterial Vaccine

الوضع إذن:

Authorized

تاريخ الترخيص:

1999-08-10

خصائص المنتج

Amended Pages: February 2021
AN: 01204/2020
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Bovilis Bovivac S
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCES:
Formalin killed cells of _Salmonella dublin_ strain S342/70
1 x 10
9
cells
Formalin killed cells of _Salmonella typhimurium_ strain S341/70
1 x 10
9
cells
ADJUVANT:
Aluminium hydroxide gel
200 mg
EXCIPIENTS:
The vaccine contains thiomersal as a preservative.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of cattle in order to induce serological
and colostral antibody
production against _Salmonella dublin_ and _Salmonella typhimurium_
and in the face of an
outbreak to reduce _Salmonella typhimurium _infections when used under
field conditions as
part of an overall herd management programme. Bovilis Bovivac S may
also contribute to
reducing _S. typhimurium_ contamination of the environment.
Specific experimental data to quantify the duration of immunity or the
degree of protection
from colostral antibodies has not been generated.
Significant levels of immunity cannot be expected until two weeks
after the second dose of
the primary vaccination course.
Amended Pages: February 2021
AN: 01204/2020
Page 2 of 5
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS
None.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
All stock showing overt clinical signs of salmonellosis at the time of
the initial vaccination
programme should receive appropriate treatment and be fully vaccinated
once they have
recovered. Any unvaccinated stock must be managed separately to
vaccinated stock, with
no contact between the groups. Hygiene precautions must be instituted,
where possible, to
prevent transfer of infection from one group to another.
All animals of a herd should be vaccinated.
The effect of maternally d